People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Other Technology, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ivantis, Inc. | — | Other Technology | Series C | $101.1M | $785.7M | 2014 |
| Forma Therapeutics Holdings LLC | — | Other | Series C | $60.1M | $171.5M | 2011 |
| Artisan Pharma, Inc. | — | Biotechnology | Series B | $50.0M | $119.1M | 2009 |
Thong-Yuen Poon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thong-Yuen Poon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 1 | 17 |
| Bruce Feuchter | 1 | 12 |
| Tara Butler | 1 | 12 |
| John Nehra | 1 | 11 |
| Douglas Roeder | 1 | 5 |
| Peter Finn | 1 | 5 |
| Georg Nebgen | 1 | 5 |
| Hironori Hozoji | 1 | 4 |
| Alexis A. Borisy | 1 | 3 |
| Jeffrey D. Wager | 1 | 3 |
| John Costantino | 1 | 2 |
| Steven Hall | 1 | 2 |
| Steven Tregay, Ph.D. | 1 | 2 |
| Michael A. Foley | 1 | 2 |
| Randy Alexander | 1 | 2 |
| David Van Meter | 1 | 2 |
| Albert Graf | 1 | 2 |
| Philippe Chambon | 1 | 2 |
| Christopher Shen | 1 | 2 |
| Ben Gust | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.